Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee.
about
Progress in molecular-based management of differentiated thyroid cancerAcoustic Radiation Force Impulse Elastography: A Useful Tool for Differential Diagnosis of Thyroid Nodules and Recommending Fine-Needle Aspiration: A Diagnostic Accuracy Study.Acoustic radiation force impulse imaging: a new tool for the diagnosis of papillary thyroid microcarcinoma.Implication of intracellular localization of transcriptional repressor PLZF in thyroid neoplasms.Increasing thyroid cancer incidence in Lithuania in 1978-2003.GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma.Association between BRAFV600E mutation and the clinicopathological features of solitary papillary thyroid microcarcinoma.Total tumour diameter is superior to unifocal diameter as a predictor of papillary thyroid microcarcinoma prognosis.Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer.Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways.Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma.Prognostic utility of BRAF mutation in papillary thyroid cancer.Benign and malignant nodular thyroid disease in acromegaly. Is a routine thyroid ultrasound evaluation advisable?The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study.BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review.Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea.Differences in the Form of Presentation between Papillary Microcarcinomas and Papillary Carcinomas of Larger Size.Evolution of differentiated thyroid cancer: a decade of thyroidectomies in a single institution.Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005.Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects.Is follow-up BRAF(V600E) mutation analysis helpful in the differential diagnosis of thyroid nodules with negative results on initial analysis?Coexistence of Histologically Confirmed Hashimoto's Thyroiditis with Different Stages of Papillary Thyroid Carcinoma in a Consecutive Chinese Cohort.The Frequency and Clinical Implications of the BRAF(V600E) Mutation in Papillary Thyroid Cancer Patients in Korea Over the Past Two Decades.Recent advances in molecular diagnosis of thyroid cancer.Higher rate of BRAF mutation in papillary thyroid cancer over time: a single-institution study.Uncommon GNAQ, MMP8, AKT3, EGFR, and PIK3R1 mutations in thyroid cancers.Thyroid cancer incidence among active duty U.S. military personnel, 1990-2004Standard and emerging therapies for metastatic differentiated thyroid cancer.Assessment of genetic mutations in the XRCC2 coding region by high resolution melting curve analysis and the risk of differentiated thyroid carcinoma in Iran.The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic casesThe Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese PatientsSCF(β-TRCP) suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2.Explaining the increasing incidence of differentiated thyroid cancer.BRAF mutation in papillary thyroid carcinomaTMP21 modulates cell growth in papillary thyroid cancer cells by inducing autophagy through activation of the AMPK/mTOR pathway.A 2016 Italian Survey about Guidelines and Clinical Management of Thyroid Nodules.Challenges of thyroid cancer management in amiodarone-treated patients: a case report.Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case-control study in New CaledoniaExpression of DNA repair proteins MSH2, MLH1 and MGMT in human benign and malignant thyroid lesions: an immunohistochemical study.Clinical significance of preoperative detection of serum p53 antibodies and BRAF(V600E) mutation in patients with papillary thyroid carcinoma.
P2860
Q26999887-8DB36A5D-31FB-4C46-AD9E-E63D59FAD208Q30400392-F92A162A-2BBD-4139-9181-9511A58A7E90Q30434576-105F7E2A-1C22-406B-8335-BB19E003489AQ31170872-EAC79A69-68C6-4F4B-95FE-1C9B40446BDEQ33265958-2F337AB1-8E67-4A0A-A16E-ECEC91AE1987Q33397349-57379EAD-CA61-4D74-812D-224DB303A9FBQ33597740-E66300CA-1A81-44D5-8A87-65676E8584E7Q33687689-06FF3EFE-BD8D-4DB4-AB94-1D27D88FBB13Q33707821-D08B65D3-26C2-4939-82E4-209274EB4197Q33736109-8923535A-0D37-45B8-AA59-2297BF6AC8A6Q33750895-C782751D-F2BE-4765-B93A-98B3444C5AA5Q33771120-42F07E6C-BD2C-4FBF-B000-E89AB80C2DB1Q34050636-808BEDE0-FE9A-40AD-BF62-AB0AB805D58EQ34113199-799E2121-5B8C-4A3B-BFFC-EE0C1959CB91Q34140160-8217B519-7553-4876-9EE5-7432982D27B4Q34174380-6E9A0C05-62F4-455B-83D2-2EC4A43241EFQ34442703-6668D39D-2BE8-4677-B90C-0AD6FAA19B5CQ34472004-D8B34167-C1CD-48AB-B3AC-99AAEFBB5C64Q34604789-2A97051F-2442-4080-B837-515800F1843EQ34624429-B1DA3C71-FA4D-453E-87E4-4F1103BE7988Q34625948-7D82BA05-EB2F-44B4-9448-DF5537C1251FQ34628032-1AB54922-EB1E-4DA0-BA6E-32D0D00F02C5Q34839781-5803FB19-E18D-4579-A750-F403FC732AEEQ34985320-16AF6BA0-2E90-4809-8FB7-04EB8B411DC1Q35091350-0F4F5300-0620-4EB4-AB8C-6AE3BFDA4231Q35097324-F576168A-6A04-4618-9B9A-19C65AD9819CQ35535615-AF29B1BE-12DE-40ED-87D2-DA76DED2BEF1Q35583906-AC432007-AE7B-4C9D-8314-472FB83D80F5Q35855423-ED2BD76A-AD76-4C0C-B16F-EDFB7B04542DQ35860194-DC0316EB-BE25-4D02-8AE5-DDF3A8C24B65Q35932262-65CDE3D9-1219-4650-AF87-B42B60B3510BQ36118305-D1B4FB87-8C2C-4259-8CF8-38CDB3FF7930Q36131201-63FFFD99-9703-469B-940F-1E17D435A151Q36238518-B5018940-C6ED-47E3-BE9C-4B404F881223Q36261540-F0914A01-03E3-4276-9E3C-98722B587059Q36394563-0648257F-7A03-455A-93FD-D645663E9548Q36399019-014A85BC-2C0E-4A3C-ACBD-334BE9F74CB8Q36417523-352293CD-85B7-49AC-8127-9A6AE1F02806Q36473867-AD3499B0-42FB-43A3-BBA7-C5C24ABAA65EQ36493086-2C751903-2EBF-414B-8D56-CC8A758EED4E
P2860
Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Increased incidence of thyroid ...... ench Thyroid Cancer Committee.
@ast
Increased incidence of thyroid ...... ench Thyroid Cancer Committee.
@en
type
label
Increased incidence of thyroid ...... ench Thyroid Cancer Committee.
@ast
Increased incidence of thyroid ...... ench Thyroid Cancer Committee.
@en
prefLabel
Increased incidence of thyroid ...... ench Thyroid Cancer Committee.
@ast
Increased incidence of thyroid ...... ench Thyroid Cancer Committee.
@en
P356
P1433
P1476
Increased incidence of thyroid ...... ench Thyroid Cancer Committee.
@en
P2093
Laurence Chérié-Challine
Thyroid Cancer Committee
P304
P356
10.1089/THY.2004.14.1056
P577
2004-12-01T00:00:00Z